All Stories

  1. Thyreoglobulin
  2. The Effects of Obesity on Lung Physiology, the Prevalence and Severity of Chronic Pulmonary Diseases, and Inhalation Treatment
  3. Development of Co-Amorphous Systems for Inhalation Therapy—Part 2: In Silico Guided Co-Amorphous Rifampicin–Moxifloxacin and –Ethambutol Formulations
  4. Better GRAS than sorry: Excipient toxicity in pulmonary formulations
  5. Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success
  6. Immune Modulation with Nanodiscs: Surface Charge Dictates Cellular Interactions and Activation of Macrophages and Dendritic-like Cells
  7. Skin Sensitization Potential of Sensitizers in the Presence of Metal Oxide Nanoparticles In Vitro
  8. Personalization of lipid-based oral dosage forms via filament-based 3D-printing
  9. Archaeosomes for Oral Drug Delivery: From Continuous Microfluidics Production to Powdered Formulations
  10. Animals in Respiratory Research
  11. Pars Distalis and Pars Tuberalis Thyroid-Stimulating Hormones and Their Roles in Macro-Thyroid-Stimulating Hormone Formation
  12. Lipid Nanoparticles as a Shuttle for Anti-Adipogenic miRNAs to Human Adipocytes
  13. Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung
  14. The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
  15. Assessment of Carbon Nanotubes on Barrier Function, Ciliary Beating Frequency and Cytokine Release in In Vitro Models of the Respiratory Tract
  16. Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease
  17. Non-Cellular Layers of the Respiratory Tract: Protection against Pathogens and Target for Drug Delivery
  18. Replacement Strategies for Animal Studies in Inhalation Testing
  19. Acute Respiratory Distress Syndrome: Focus on Viral Origin and Role of Pulmonary Lymphatics
  20. Initial Biological Assessment of Upconversion Nanohybrids
  21. “Biology and Medicine”: A Section of Nanomaterials Addressing Interactions of Nanomaterials with All Forms of Life
  22. Nanoparticles: Promising Auxiliary Agents for Diagnosis and Therapy of Thyroid Cancers
  23. Replacement Strategies for Animal Studies in Inhalation Testing
  24. Cytokine-Mediated Inflammation in the Oral Cavity and Its Effect on Lipid Nanocarriers
  25. Screening for Effects of Inhaled Nanoparticles in Cell Culture Models for Prolonged Exposure
  26. On Absorption Modeling and Food Effect Prediction of Rivaroxaban, a BCS II Drug Orally Administered as an Immediate-Release Tablet
  27. Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation
  28. Different Sensitivity of Macrophages to Phospholipidosis Induction by Amphiphilic Cationic Drugs
  29. Issues with Cancer Spheroid Models in Therapeutic Drug Screening
  30. Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients
  31. Impact of drug particle shape on permeability and cellular uptake in the lung
  32. Functional dextran amino acid ester particles derived from N-protected S-trityl-L-cysteine
  33. Cytotoxicity screening of emulsifiers for pulmonary application of lipid nanoparticles
  34. Biological Obstacles for Identifying In Vitro-In Vivo Correlations of Orally Inhaled Formulations
  35. Delivery of Dry Powders to the Lungs: Influence of Particle Attributes from a Biological and Technological Point of View
  36. An automatable platform for genotoxicity testing of nanomaterials based on the fluorometric γ-H2AX assay reveals no genotoxicity of properly surface-shielded cadmium-based quantum dots
  37. Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles
  38. The Development of Indicator Cotton Swabs for the Detection of pH in Wounds
  39. Amphiphilic coatings for the protection of upconverting nanoparticles against dissolution in aqueous media
  40. An in vitro and in silico study of the impact of engineered surface modifications on drug detachment from model carriers
  41. Cellular elimination of nanoparticles
  42. Oral uptake of nanoparticles: human relevance and the role of in vitro systems
  43. Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut Microbiota
  44. MECHANISMS IN ENDOCRINOLOGY: Impact of isolated TSH levels in and out of normal range on different tissues
  45. Permeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In Vitro
  46. In Vitro Assessment of Chronic Nanoparticle Effects on Respiratory Cells
  47. Atomic force microscopy as analytical tool to study physico-mechanical properties of intestinal cells
  48. Intracellular calcium levels as screening tool for nanoparticle toxicity
  49. Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
  50. Interactions between nano-TiO2 and the oral cavity: Impact of nanomaterial surface hydrophilicity/hydrophobicity
  51. Chemotherapy and Chemoprevention by Thiazolidinediones
  52. Analogies in the Adverse Immune Effects of Wear Particles, Environmental Particles, and Medicinal Nanoparticles
  53. Use of whole genome expression analysis in the toxicity screening of nanoparticles
  54. The current role of targeted therapies to induce radioiodine uptake in thyroid cancer
  55. The buccal mucosa as a route for TiO2nanoparticle uptake
  56. Photohardening of polymorphic light eruption patients decreases baseline epidermalLangerhans cell density while increasing mast cell numbers in the papillary dermis
  57. Toxicological Assessment of Inhaled Nanoparticles: Role of in Vivo, ex Vivo, in Vitro, and in Silico Studies
  58. Development of an Advanced Intestinal in Vitro Triple Culture Permeability Model To Study Transport of Nanoparticles
  59. Reaction of monocytes to polystyrene and silica nanoparticles in short-term and long-term exposures
  60. Mucus as Barrier for Drug Delivery by Nanoparticles
  61. Mucus as Physiological Barrier to Intracellular Delivery
  62. Gas Permeation, Mechanical Behavior and Cytocompatibility of Ultrathin Pure and Doped Diamond-Like Carbon and Silicon Oxide Films
  63. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats
  64. Nano-sized and micro-sized polystyrene particles affect phagocyte function
  65. Cellular Targets and Mechanisms in the Cytotoxic Action of Non-biodegradable Engineered Nanoparticles
  66. Titanium dioxide nanoparticles and the oral uptake-route
  67. In Vitro and In Vivo Techniques to Assess Neurotoxicity of Nanoparticles
  68. The oral cavity as a biological barrier system: Design of an advanced buccal in vitro permeability model
  69. Assessment of Long-Term Effects of Nanoparticles in a Microcarrier Cell Culture System
  70. Comparison of two in vitro systems to assess cellular effects of nanoparticles-containing aerosols
  71. Suitability of Cell-Based Label-Free Detection for Cytotoxicity Screening of Carbon Nanotubes
  72. New Diagnostic and Therapeutic Tools for Thyroid Cancer
  73. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
  74. In‐Vitro Permeability of Neutral Polystyrene Particles via Buccal Mucosa
  75. Combination of small size and carboxyl functionalisation causes cytotoxicity of short carbon nanotubes
  76. Nanoparticles in Biology and Medicine: Methods and Protocols. Edited by Mikhail Soloviev.
  77. Interspecies differences in membrane-associated protease activities of thyrocytes and their relevance for thyroid cancer studies
  78. Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties
  79. Differentiation Therapy in Thyroid Carcinoma
  80. Models for oral uptake of nanoparticles in consumer products
  81. Action of polystyrene nanoparticles of different sizes on lysosomal function and integrity
  82. Do antidiabetic medications play a specific role in differentiated thyroid cancer compared to other cancer types?
  83. Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions
  84. Cytotoxity of nanoparticles is influenced by size, proliferation and embryonic origin of the cells used for testing
  85. Evaluation of a physiologicalin vitrosystem to study the transport of nanoparticles through the buccal mucosa
  86. Fibulin-5 mutations link inherited neuropathies, age-related macular degeneration and hyperelastic skin
  87. Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation
  88. Decrease in Dipeptidyl Peptidase IV Activity is Linked to the Efficacy of Differentiating Compounds in Follicular Thyroid Carcinoma Cell Lines
  89. EP4 receptor stimulation down-regulates human eosinophil function
  90. Targeted High-Throughput Sequencing Identifies Mutations in atlastin-1 as a Cause of Hereditary Sensory Neuropathy Type I
  91. Cholesteryl ester hydrolase activity is abolished in HSL macrophages but unchanged in macrophages lacking KIAA1363
  92. Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target
  93. Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticles
  94. Efficient Phagocytosis Requires Triacylglycerol Hydrolysis by Adipose Triglyceride Lipase
  95. Proliferation analysis of the growth plate after diaphyseal midshaft fracture by 5′-bromo-2′-deoxy-uridine
  96. The Neuron: The Basis for Processing and Propagation of Information in The Nervous System
  97. Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation
  98. Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes
  99. Chitosan-4-mercaptobenzoic acid: synthesis and characterization of a novel thiolated chitosan
  100. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C
  101. Chitosan-graft-6-mercaptonicotinic Acid: Synthesis, Characterization, and Biocompatibility
  102. Postpolymerization modification of poly(pentafluorophenyl methacrylate): Synthesis of a diverse water‐soluble polymer library
  103. Efficiency of various dissociation methods for the preparation of thyroid single cell suspensions
  104. The role of nanoparticle size in hemocompatibility
  105. Dipeptidyl peptidase II is not a marker for progression in melanoma
  106. Cytotoxicity of nanoparticles independent from oxidative stress
  107. Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines
  108. Chondrocyte apoptosis enhanced at the growth plate: a physeal response to a diaphyseal fracture
  109. Antitumor Effects of Arsenic Trioxide in Transformed Human Thyroid Cells
  110. Hemocompatibility of various nanoparticles in human blood
  111. Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell lines
  112. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas
  113. Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture
  114. Retinol has specific effects on binding of thyrotrophin to cultured porcine thyrocytes
  115. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L
  116. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L
  117. Proteases in malignant tumors
  118. Regional differences and post-mortem stability of enzymatic activities in the retinal pigment epithelium
  119. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma
  120. Mammalian Bax triggers apoptotic changes in yeast
  121. Development of multibank rod retinae in deep-sea fishes
  122. Rod Outer Segment Renewal in the Retinae of Deep-sea Fish
  123. Basal lamina formation by porcine thyroid cells grown in collagen- and laminin-deficient medium
  124. Basal lamina formation by porcine thyroid cells grown in collagen- and laminin-deficient medium
  125. Patterns of rod proliferation in deep-sea fish retinae
  126. The occurrence of dopaminergic interplexiform cells correlates with the presence of cones in the retinae of fish
  127. Mammalian Müller (glial) cells express functional D2 dopamine receptors